Navigation Links
Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
Date:5/15/2012

ve and highly selective way.  For additional information please visit www.novelos.comINVESTOR CONTACTS
J. Patrick Genn, Vice President of IR  

 Anne Marie Fields, Senior Vice PresidentNovelos Therapeutics, Inc.  

 LHAPh: (858) 775-7456  

 Ph: (212) 838-3777Email: jpgenn@novelos.com 

 Email: afields@lhai.com, @LHA_IR_PR 

Novelos Therapeutics, Inc.Madison, WI

Boston, MAThis news release contains forward-looking statements.  You can identify these statements by our use of words such as "may," "expect," "believe," "anticipate," "intend," "could," "estimate," "continue," "plans," or their negatives or cognates.
Such statements are valid only as of today, and we disclaim any obligation to update this information.  These statements are only estimates and predictions and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made.  These statements are based on our current beliefs and expectations as to such future outcomes.  Drug discovery and development involve a high degree of risk.  Factors that might cause such a material difference include, among others, uncertainties related to the ability to attract and retain partners for our technologies, the identification of lead compounds, the successful preclinical development thereof, the completion of clinical trials, the FDA review process and other government regulation, our  pharmaceutical collaborators' ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, product pricing and third-party reimbursement.


'/>"/>
SOURCE Novelos Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Novelos Therapeutics Prices $5.9 Million Public Offering
3. Novelos Therapeutics Announces Dismissal of Putative Federal Securities Class Action Lawsuit
4. Novelos Therapeutics to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
5. Nonconformity of NOV002 Used in Phase 3 NSCLC Trial Sponsored by Novelos Therapeutics, Inc to NOV002 (Glutoxim(R)), Used in Phase 1/2 NSCLC and all Previous Trials
6. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
7. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
8. Echo Therapeutics Announces First Quarter 2012 Financial Results
9. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Carolina , 31. Juli 2014 ... Miami bekanntgegeben, um die ... Zentral- und Lateinamerika zu erfüllen. Die neu ausgebaute ... biologische Proben und für die Zusammenlegung von Sendungen ... wird zusätzliche Lagerkapazität bereitstellen.   Logo ...
(Date:7/31/2014)... NOTTINGHAM, England , July 31, 2014 /PRNewswire/ ... ) today announced that its subsidiary, Molecular Profiles ... that will support pharmaceutical and biotech drug developers ... Profiles, pharmaceutical development services will be supported by ... (DMPK) to give clients a smarter route into ...
(Date:7/31/2014)... 31, 2014 Auxilium Pharmaceuticals, Inc. ... biopharmaceutical company, today announced that the Company will ... its partner Asahi Kasei Pharma Corporation (Asahi Kasei). ... submission of a regulatory application to the Japanese ... ® (collagenase clostridium histolyticum) for the treatment ...
Breaking Medicine Technology:Marken erweitert regionales Logistikzentrum in Miami 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5
(Date:7/31/2014)... Reserve University medical and nursing school researchers hope ... patients who participate in clinical trials, a critical ... preventions. , For various reasonsincluding a lack of ... of cancer patients take part in trials of ... cancer patients who are eligible still don,t enroll, ...
(Date:7/31/2014)... Thousands of independent community pharmacists, ... have come together today to kick off ThoughtSpot ... , "ThoughtSpot 2014 is Good Neighbor Pharmacy’s annual ... to help their businesses thrive," stated AJ Caffentzis, ... long-standing commitment to independent community pharmacies, and at ...
(Date:7/31/2014)... India (PRWEB) July 31, 2014 Web ... an ISO 9001:2008 certified internet marketing firm, has recently ... order to make this service affordable for everyone, the ... of the service. , Web Programming Services has ... the world of brochure designing and likely expectations of ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Recently, Agebc.com, a ... dresses, has revealed its new selection of trendy mother ... them are offered at promotional prices now, up to 68% ... line by adding the new range of mother of the ... to the international clients. So far, our online shop has ...
(Date:7/31/2014)... Calif., July 31, 2014 -- A new study by ... that a peptide called caerulein can convert existing cells ... 1 diabetes-insulin-producing beta cells. The study, published online July ... a new approach to treating the estimated 3 million ... living with type 1 diabetes. , "We have found ...
Breaking Medicine News(10 mins):Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 2Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 3Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 2Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 3Health News:Web Programming Services Introduces Affordable Brochure Designing Service 2Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2Health News:A new way to generate insulin-producing cells in Type 1 diabetes 2
... with four additional law suits, after the Liver Transplant Program ... ,Orange county Superior court has been a witness ... died just waiting for the transplants; the fourth, a patient ... program transparent to gross mismanagement has to also battle the ...
... are on tenterhooks, preventing the spread of the deadly virus H5N1, ... Eastern past of France. // The farm in Versailleux,on Thursday, that ... the lake where wild ducks were among the first to get ... ,This is perhaps the first time that a European Union farm ...
... prison in Guantanamo Bay to force feed the prisoners ... // through their noses has raised controversies among medical ... the fundamental principles of medical ethics. ,In ... targeted at extension of co-operation by the detainees. A ...
... mosquito-borne disease for which there is no known cure or ... of La Reunion Island // on Indian Ocean. As Nearly ... Xavier Bertrand, French Health Minister. ,More than 130, ... mortalities could be related directly or indirectly to the epidemic ...
... and unwholesomeness of visually appetizing foods, sugar coated cereals ... food strategies,// and yo-yo to consumer palettes, dictated by ... to keep heart disease and cancer at bay. ... a nutrition expert at the University of Maryland, ...
... offered insights into why Africans have an increased susceptibility ... compared to whites. // Worldwide, approximately more than ... 2 million people die due to the same every ... to official sources, the incidence of TB is eight ...
Cached Medicine News:Health News:Medical Ethics Violated By Prison Officials In Guantanamo Bay 2Health News:Wholly Ingrained: White or Brown? Food War Going Racist? Get to the Heart of the Matter 2Health News:Vitamin D May Help In Fight Against Tuberculosis 2
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
... Reviews enable all those involved with healthcare ... the very latest evidence in their field ... harder each year as the volume of ... by delivering the best single source available ...
... topics included: Ergogenic aids, anabolic steroids, ... swimming, skiing, tennis, common sports problems, ... cardiology for athletes, exercise, exercise (treadmill) ... injuries, heat-related illness, acclimatization, neuropraxia, overtraining ...
Pocket Sports Medicine is the result of a collaboration between outstanding Editors and Contributors. The program covers the field so that both specialists and general orthopedists will find expert g...
Medicine Products: